Da Ma Selected Research

cucurbit(n)uril (cucurbituril)

8/2018	Pro-guest and acyclic cucurbit[n]uril conjugated polymers for the controlled release of anti-tumor drugs.
4/2012	Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Da Ma Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 06/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2008
4	Squamous Cell Carcinoma of Head and Neck 10/2021 - 06/2017
2	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2020 - 01/2017
2	Wounds and Injuries (Trauma) 01/2020 - 01/2020
2	Tauopathies 01/2019 - 03/2016
1	Abdominal Obesity 06/2022
1	Body Weight (Weight, Body) 06/2022
1	Polypoidal Choroidal Vasculopathy 02/2022
1	Macular Degeneration (Age-Related Maculopathy) 02/2022
1	Phototoxic Dermatitis (Phototoxicity) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Cognitive Dysfunction 01/2022
1	Retinal Diseases 12/2021
1	Cryptorchidism (Undescended Testes) 01/2021
1	Dementia (Dementias) 10/2020
1	Melanoma (Melanoma, Malignant) 01/2019
1	Carcinogenesis 01/2019
1	Rupture 04/2018
1	Mouth Neoplasms (Oral Cancer) 01/2018
1	Ulcer 01/2018
1	Fibrosis (Cirrhosis) 01/2017
1	Multiple Sclerosis 01/2017
1	Atrophy 03/2016
1	Lymphatic Metastasis 01/2016
1	Cataract (Cataracts) 11/2013
1	Ovarian Neoplasms (Ovarian Cancer) 04/2012
1	Tuberculosis (Tuberculoses) 05/2010
1	Liver Neoplasms (Liver Cancer) 01/2005
1	Ascites 01/2005

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2017
4	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2005
2	Retinaldehyde (Retinal)IBA 02/2022 - 12/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2020 - 04/2012
2	Pharmaceutical PreparationsIBA 02/2020 - 05/2010
2	cucurbit(n)uril (cucurbituril)IBA 08/2018 - 04/2012
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	EndotoxinsIBA 01/2022
1	Talaporfin (talaporfin sodium)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	PorphyrinsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 10/2021
1	Tyrosine (L-Tyrosine)FDA Link 10/2021
1	AnthracyclinesIBA 01/2021
1	inhibin BIBA 01/2021
1	ProdrugsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2020
1	Antineoplastic Agents (Antineoplastics)IBA 02/2020
1	CollagenIBA 01/2020
1	pigment epithelium-derived factorIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	Thrombospondin 1IBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	Neuropilin-1IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Angiopoietin-2IBA 01/2020
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2020
1	SuspensionsIBA 01/2019
1	CalnexinIBA 01/2019
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 01/2019
1	PolymersIBA 08/2018
1	MicrogelsIBA 04/2018
1	ThrombomodulinIBA 01/2018
1	AcidsIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 08/2017
1	Temozolomide (Temodar)FDA LinkGeneric 08/2017
1	Cysteine Proteases (Cysteine Protease)IBA 06/2017
1	CalpainIBA 06/2017
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 03/2016
1	Small Interfering RNA (siRNA)IBA 06/2014
1	baysilon (polydimethylsiloxane)IBA 11/2013
1	SolutionsIBA 11/2013
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2013
1	Ethambutol (Myambutol)FDA LinkGeneric 05/2010
1	Cholinergic Agents (Cholinergics)IBA 12/2008
1	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2008
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2008
1	Immunoglobulin G (IgG)IBA 01/2005

Therapy/Procedure

4	Therapeutics 04/2020 - 03/2016
2	Immunotherapy 10/2019 - 01/2019
1	Aftercare (After-Treatment) 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Lasers (Laser) 01/2021
1	Intradermal Injections 01/2020